Hoshi Iryo-Sanki Co Ltd

Hoshi Iryo-Sanki maintains a strong liquidity position, with cash and equivalents amounting to ¥10.63 billion, representing 43.2% of total assets. The company's liquidity FPT (free cash flow to total liabilities) is robust, with free cash flow of ¥1.54 billion and total liabilities of ¥6.16 billion, indicating a liquidity buffer of 25.0%. The current ratio of 3.17 further supports its ability to meet short-term obligations. Profitability metrics show a return on equity (ROE) of 7.94% and return on assets (ROA) of 5.95%, both below the industry median for medical equipment and supplies firms. The company's operating margin of 13.1% is in line with the sector average, but its net margin of 9.7% is slightly below the median, suggesting potential inefficiencies in cost management or tax strategy. The company's revenue is distributed across five segments, with the Medical Gas-related and Household Medical-related segments being the primary contributors. Geographically, the company is concentrated in Japan, with no disclosed international operations. This concentration exposes the company to domestic regulatory and economic risks. Outlook data indicates a projected revenue growth of 2.3% for the current fiscal year and 1.8% for the next, driven by stable demand in the domestic healthcare market. Historical revenue growth has averaged 3.1% annually over the past five years, suggesting a moderate but consistent expansion. Risk assessment highlights low liquidity and dilution risk, with no immediate filing-based flags detected. The company's debt-to-equity ratio of 0.06 is well below the industry median, indicating a conservative capital structure. No dilution potential is identified in the basic shares outstanding, and no adjustments have been applied to valuation metrics. Recent filings and transcripts show no material changes in business strategy or financial position. The company continues to focus on its core medical gas and home healthcare segments, with no disclosed M&A activity or significant capital projects in the near term.